Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01972737
Recruitment Status : Completed
First Posted : October 30, 2013
Last Update Posted : April 5, 2017
Information provided by (Responsible Party):
Thomas Jefferson University ( Sidney Kimmel Cancer Center at Thomas Jefferson University )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 3, 2014
  Actual Study Completion Date : January 13, 2016

Publications automatically indexed to this study by Identifier (NCT Number):